PuglisiF., CesselliD., DamanteG., PellizzariL., BeltramiC.A., Di LoretoC.: Expression of PAX-8, P53 and bcl2 in human benign and malignant thyroid diseases.Anticancer Res, 20: 311–316, 2000.
2.
RosP., RossiD.R., AcebronA., SantistebanP.: Thyroid-specific gene expression in the multistep process of thyroid carcinogenesis.Biochimie, 81: 389–396, 1999.
3.
KrollT.G., SarrafP., PecciariniL., ChenC.J., MuellerE., Spiegel-manB.M., FletcherJ.A.: PAX8-PPAR gamma 1 fusion oncogene in human thyroid carcinoma.Science, 289: 1357–1360, 2000.
4.
de CapoaA., GrappelliC., FebboF.R., SpanoA., NiveleauA., CafollaA., CordoneI., FoaR.: Methylation levels of normal and chronic lymphocytic leukemia B lymphocytes: computer-assisted quantitative analysis of anti-5-methylcytosine antibody binding to individual nuclei.Cytometry, 36: 157–159, 1999.
5.
TomimoriE., PedrinolaF., CavaliereH., KnobelM., Medeiros NetoG.: Prevalence of incidental thyroid disease in a relatively low iodine intake area.Thyroid, 5: 273–276, 1995.
6.
VanderpumpM.P., TunbridgeW.M., FrenchJ.M., AppletonD., BatesD., ClarkF., Grimley EvansJ., HasanD.M., RodgersH., TunbridgeF.A.U.: The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey.Clin Endocrinol, 43: 55–68, 1995.
GiovagnoliM.R., PisaniT., DruscoA., ScardellaL., AntonaciA., VecchioneA.: Fine needle aspiration biopsy in the preoperative management of patients with thyroid nodules.Anticancer Res, 18: 3741–3745, 1998.
